ArticleToxicon: X2020

High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study.

Gerard E Francisco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.